Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CC17 group B Streptococcus exploits integrins for neonatal meningitis development
Romain Deshayes de Cambronne, … , Claire Poyart, Julie Guignot
Romain Deshayes de Cambronne, … , Claire Poyart, Julie Guignot
Published January 19, 2021
Citation Information: J Clin Invest. 2021;131(5):e136737. https://doi.org/10.1172/JCI136737.
View: Text | PDF
Research Article Infectious disease Microbiology

CC17 group B Streptococcus exploits integrins for neonatal meningitis development

  • Text
  • PDF
Abstract

Group B Streptococcus (GBS) is the major cause of human neonatal infections. A single clone, designated CC17-GBS, accounts for more than 80% of meningitis cases, the most severe form of the infection. However, the events allowing blood-borne GBS to penetrate the brain remain largely elusive. In this study, we identified the host transmembrane receptors α5β1 and αvβ3 integrins as the ligands of Srr2, a major CC17-GBS–specific adhesin. Two motifs located in the binding region of Srr2 were responsible for the interaction between CC17-GBS and these integrins. We demonstrated in a blood-brain-barrier cellular model that both integrins contributed to the adhesion and internalization of CC17-GBS. Strikingly, both integrins were overexpressed during the postnatal period in the brain vessels of the blood-brain barrier and blood-cerebrospinal fluid barrier and contributed to juvenile susceptibility to CC17 meningitis. Finally, blocking these integrins decreased the ability of CC17-GBS to cross into the CNS of juvenile mice in an in vivo model of meningitis. Our study demonstrated that CC17-GBS exploits integrins in order to cross the brain vessels, leading to meningitis. Importantly, it provides host molecular insights into neonate’s susceptibility to CC17-GBS meningitis, thereby opening new perspectives for therapeutic and prevention strategies of GBS-elicited meningitis.

Authors

Romain Deshayes de Cambronne, Agnès Fouet, Amandine Picart, Anne-Sophie Bourrel, Cyril Anjou, Guillaume Bouvier, Cristina Candeias, Abdelouhab Bouaboud, Lionel Costa, Anne-Cécile Boulay, Martine Cohen-Salmon, Isabelle Plu, Caroline Rambaud, Eva Faurobert, Corinne Albigès-Rizo, Asmaa Tazi, Claire Poyart, Julie Guignot

×

Figure 3

α5β1 promotes adhesion and invasion of CC17-GBS in a simplified model of CHO cells.

Options: View larger image (or click on image) Download as PowerPoint
α5β1 promotes adhesion and invasion of CC17-GBS in a simplified model of...
(A and B) CHO, CHO-α5β1, CHO-αvβ3, and CHO-ICAM1 were infected with GBS strains for 1 hour, and then analyzed by (A, B, and E) immunofluorescence or (C, D, and F) CFU counts. (A) Representative micrographs of untransfected or transfected CHO cells infected with CC17-GFP (green). Nuclei were labeled with DAPI (blue) and actin with phalloidin (gray). Scale bar: 10 μm. (B) Representative micrographs of transfected CHO-α5β1 infected with CC17-GFP strain (green) and immunostained with anti–α5 integrin antibody (red). Two independent fields from the same experiment are shown. Scale bar: 10 μm. (C) Adhesion of a CC17 or a non-CC17 (CC23) strain on transfected or untransfected CHO cells was quantified. Results are expressed as the percentage of adhesion obtained on transfected cells minus that obtained on untransfected cells. (D) Adhesion level of WT CC17 and derived strains on CHO-α5β1 normalized to WT CC17 adhesion. Anti-Srr2 antibody was diluted 1:500. (E) CC17-GFP strain (green) was used to infect CHO-α5β1. Differential staining was used to distinguish extracellular from intracellular bacteria. GBS outside of host cells have green (GFP) and red fluorescence (anti-GBS) and appear yellow/red, whereas bacteria inside host cells have green fluorescence only. Nuclei were labeled with DAPI (blue) and actin was stained using phalloidin (gray). Scale bar: 10 μm. Boxed area corresponds to magnification of inset. (F) Invasion of CC17 strain or Δsrr2-derived strain on untransfected CHO or CHO-α5β1 was quantified by CFU counts. All experiments were performed at least 3 times with each condition. Statistical analysis: Data shown are mean ± SEM of at least 3 independent experiments realized in triplicate. One-way ANOVA with Tukey’s (C and F) or Dunn’s (D) multiple-comparison test was performed. NS, nonsignificant; *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts